Anti-mycoplasmal and anti-inflammatory effect of Origanum vulgare extract against Mycoplasma hyopneumoniae

Mycoplasma hyopneumoniae에 대한 Origanum vulgare 추출물의 항마이코플라즈마 및 항염증 효과

  • Choi, Myung-Jin (College of Veterinary Medicine, Kyungpook National University) ;
  • Hwang, Mi-Hyun (College of Veterinary Medicine, Kyungpook National University) ;
  • Choi, Jae-Young (College of Veterinary Medicine, Kyungpook National University) ;
  • Lee, Joong-Su (College of Veterinary Medicine, Kyungpook National University) ;
  • Park, Seung-Chun (College of Veterinary Medicine, Kyungpook National University)
  • Accepted : 2009.09.02
  • Published : 2009.09.30


In the present study, ten herbal extracts, Citrus unshiu Markovich, root and stem of Berberis koreana, Morus alba, Dendrobium moniliforme, Aster gramineus, A. scabar, Alisma canaliculatum, Fallopia japonica and Origanum (O.) vulgare were determined to examine anti-mycoplasmal activity. Among them, O. vulgare extract (OVE) showed strong anti-mycoplasmal activity and was analyzed by gaschromatography/ mass spectrometry (GC/MS). As the results, OVE was consisted of carvacrol (68.78%), o-cymene (9.80%), terpinene (7.61%) and thymol (4.03%) as main ingredients. To investigate inflammatory activity by intact pathogenic Mycoplasma hyopneumoniae (M. hyo) at 30 $\mu$g/ml, we examined induced transcription of proinflammatory cytokines such as cyclooxygenase-2, tumor necrosis factor-a, interleukin (IL)-1, IL-6 and inducible nitric oxide synthase in RAW 264.7 cells. With the above results, we further investigated whether OVE could reduce inflammation induced by M. hyo at minimal inhibitory concentration. The result showed that 32 $\mu$g/ml of OVE inhibited nitric oxide production by 60%. This study also evaluated the combination of OVE with antibacterials against M. hyo for application. Based on these results, it could be concluded that M. hyo induces inflammation in RAW 264.7 cells and OVE protects this inflammation, indicating that OVE may be useful for industrial animals.


Supported by : 한국학술진흥재단


  1. 김재영, 이용섭, 임융호. 수종의 한약재 추출물의 항 산화 활성 및 항진균 활성. 한국미생물생명공학회지 2009, 37, 42-48
  2. 김홍태, 이우원, 정경태, 이승미, 손은정, 이강록, 김금향, 이동수, 이근우. 유통되는 쇠고기에서 분리한 대장균의 항생제 내성 조사.연구. 한국가축위생학 회지 2008, 31, 17-29
  3. 송동준, 서동균, 이춘식, 배영찬, 김원일, 김봉환. 돼지 호흡기질병 병인체의 항균제 감수성 조사. 한국 가축위생학회지 2000, 23, 19-28
  4. 이정아, 김성국, 조옥숙, 오강희, 박영구. 돼지의 호흡 기질병 감염상황 조사. 한국가축위생학회지 1997, 20, 27-36
  5. 이함희, 제임스 라, 한정희. 돼지 마이코플라즈마 폐렴 예방백신의 접종시기별 방어효과에 관한 연구. 한국가축위생학회지 2008, 31, 291-303
  6. Hannan PC, Windsor HM, Ripley PH. In vitro susceptibilities of recent field isolates of Mycoplama hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae. Res Vet Sci 1997, 63, 157-160
  7. Hwang MH, Chang ZQ, Kang EH, Lim JH, Yun HI, Rhee MH, Jeong KS, Park SC. Surfactin C inhibits Mycoplasma hyopneumoniae-induced transcription of proinflammatory cytokines and nitric oxide production in murine RAW 264.7 cells. Biotechnol Lett 2008, 30, 229-233
  8. Hwang MH, Kim MH, Gebru E, Jung BY, Lee SP, Park SC. Killing rate curve and combination effects of surfactin C produced from Bacillus subtilis complex BC1212 against pathogenic Mycoplasma hyopneumoniae. World J Microbiol Biotechnol 2008, 24, 2277- 2282
  9. Ino A, Hasegawa Y, Murabayashi A. Total synthesis of the antimycoplasma antibiotic micacocidin. Tetrahedron Lett 1998, 39, 3509-3512
  10. Kim HG, Yoon DH, Kim CH, Shrestha B, Chang WC, Lim SY, Lee WH, Han SG, Lee JO, Lim MH, Kim GY, Choi S, Song WO, Sung JM, Hwang KC, Kim TW. Ethanol extract of inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells. J Med Food 2007, 10, 80-89
  11. Madsen ML, Nettleton D, Thacker EL, Edwards R, Minion FC. Transcriptional Profiling of Mycoplasma hyopneumoniae during Heat Shock Using Microarrays. Infect Immun 2006, 74, 160-166
  12. Maes D, Segales J, Meyns T, Sibila M, Pieters M, Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol 2008, 126, 297-309
  13. Mockute D, Bernotiene G, Judzentiene A. The essential oil of Origanum vulgare L. ssp. vulgare growing wild in Vilnius district (Lithuania). Phytochemistry 2001, 57, 65-69
  14. Park CS, Park GS, Kim ML. Effect of Oregano (Origanum vulgare L.) on the survival of Escherichia coli O157:H7 and staphylococcus aureus 196E during cold storage. Korean J Soc Food SCI 1997, 13, 440- 447
  15. Park SC, Hsu WH, Yun HI, Jung KS, Jang KH, Oh TH, Lee KW, YI SJ. Changes of intracellular calcium after administration of pathogenic and nonpathogenic Mycoplasmas in porcine ciliated tracheal cells. J Vet Clin Med 2001, 18, 93-97
  16. Park SC, Yibchok-Anun S, Cheng H, Young TF, Thacker EL, Minion FC, Ross RF, Hsu WH. Mycoplasma hyopneumoniae increases intracellular calcium release in porcine ciliated tracheal cells. Infect Immun 2002, 70, 2502-2506
  17. Ruiz A, Galina L, Pijoan C. Mycoplasma hyopneumoniae colonization of pigs sired by different boars. Can J Vet Res 2002, 66, 79-85
  18. Santoro GF, das Gracas Cardoso M, Guimaraes LG, Salgado AP, Menna-Barreto RF, Soares MJ. Effectof Oregano (Origarum vulgare L.) and thyme (Thymus vulgaris L.) essential oils on Trypanosoma cruzi (Protozoa: Kinetoplastida) growth and ultrastructure. Parasitol Res 2007, 100, 783-790
  19. Savini I, Arnone R, Catani MV, Avigliano L. Origanum vulgare induces apoptosis in human colon cancer caco2 cells. Nutr Cancer 2009, 61, 381-389
  20. Schafer ER, Oneal MJ, Madsen ML, Minion FC. Global transcriptional analysis of mycoplasma hyopneumoniae following exposure to hydrogen peroxide. Microbiology 2007, 153, 3785-3790
  21. Stipkovits L, Miller D, Glavits R, Fodor L, Burch D. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Can J Vet Res 2001, 65, 213-222
  22. Tajima M, Yagihashi T. Interaction of Mycoplasma hyopneumoniae with the porcine respiratory epithelium as observed by electron microscopy. Infect Immun 1982, 37, 1162-1169
  23. Wenzel RP, Craven RB, Davies JA, Hendley JO, Hamory BH, Gwaltney JM Jr. Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy. J Infect Dis 1976, 134, 571-576
  24. Zhang Q, Young TF, Ross RF. Microtiter plate adherence assay and receptor analogs for Mycoplasma hyopneumoniae. Infect Immun 1994, 62, 1616-1622